Salim, Derya Kivrak <br/><br/>
Molecular types and neoadjuvant chemotherapy in patients with breast cancer- while molecular shifting is more common in luminal a tumors, the pathologic complete response is most frequently observed in her-2 like tumors.  [electronic resource] 

 -  Asian Pacific journal of cancer prevention : APJCP  2014 
 - 9379-83 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>2476-762X 
<br/><br/><label>Standard No.: </label>10.7314/apjcp.2014.15.21.9379  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Biomarkers, Tumor--metabolism<br/>Biopsy, Needle<br/>Breast Neoplasms--drug therapy<br/>China<br/>Databases, Factual<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunohistochemistry<br/>Neoadjuvant Therapy--methods<br/>Neoplasm Invasiveness--pathology<br/>Neoplasm Staging<br/>Receptor, ErbB-2--metabolism<br/>Receptors, Estrogen--analysis<br/>Receptors, Progesterone--analysis<br/>Retrospective Studies<br/>Risk Assessment<br/>Survival Analysis<br/>Treatment Outcome